[go: up one dir, main page]

MX2019002425A - Micro ácidos ribonucleicos como biomarcadores para la endometriosis. - Google Patents

Micro ácidos ribonucleicos como biomarcadores para la endometriosis.

Info

Publication number
MX2019002425A
MX2019002425A MX2019002425A MX2019002425A MX2019002425A MX 2019002425 A MX2019002425 A MX 2019002425A MX 2019002425 A MX2019002425 A MX 2019002425A MX 2019002425 A MX2019002425 A MX 2019002425A MX 2019002425 A MX2019002425 A MX 2019002425A
Authority
MX
Mexico
Prior art keywords
endometriosis
micrornas
biomarkers
mirna
characterization
Prior art date
Application number
MX2019002425A
Other languages
English (en)
Inventor
Taylor Hugh
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of MX2019002425A publication Critical patent/MX2019002425A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)

Abstract

Se describen en la presente composiciones y metodos utiles para el diagnostico, evaluacion y caracterizacion de la endometriosis en un sujeto que lo necesite, con base en el nivel de expresion de al menos un miARN que se asocia con la endometriosis.
MX2019002425A 2016-08-30 2017-08-30 Micro ácidos ribonucleicos como biomarcadores para la endometriosis. MX2019002425A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662381130P 2016-08-30 2016-08-30
PCT/US2017/049284 WO2018044979A1 (en) 2016-08-30 2017-08-30 Micrornas as biomarkers for endometriosis

Publications (1)

Publication Number Publication Date
MX2019002425A true MX2019002425A (es) 2019-08-16

Family

ID=61301726

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002425A MX2019002425A (es) 2016-08-30 2017-08-30 Micro ácidos ribonucleicos como biomarcadores para la endometriosis.

Country Status (11)

Country Link
US (3) US10982282B2 (es)
EP (1) EP3506912B1 (es)
JP (2) JP2019528081A (es)
KR (1) KR20190057305A (es)
CN (1) CN109890394A (es)
AU (1) AU2017319325A1 (es)
BR (1) BR112019004075A2 (es)
CA (1) CA3035429A1 (es)
MX (1) MX2019002425A (es)
SG (2) SG11201901834WA (es)
WO (1) WO2018044979A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015148919A2 (en) 2014-03-27 2015-10-01 Yale University Circulating micrornas as biomarkers for endometriosis
SG11201901834WA (en) 2016-08-30 2019-03-28 Univ Yale Micrornas as biomarkers for endometriosis
EP3676395A4 (en) * 2017-08-30 2021-09-01 Dot Laboratories, Inc. METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF ENDOMETRIOSIS
US12286629B2 (en) 2018-07-13 2025-04-29 Yale University Compositions and methods for treating endometriosis
KR102089559B1 (ko) 2018-08-31 2020-03-16 차의과학대학교 산학협력단 난소의 fsh에 대한 반응성의 진단 또는 예측용 바이오마커 및 이의 용도
US11315660B2 (en) 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
EP3873487A4 (en) * 2018-10-31 2022-08-03 Yale University QUANTITATIVE ALGORITHM FOR ENDOMETRIOSIS
WO2020146544A1 (en) * 2019-01-09 2020-07-16 Research Institute At Nationwide Children's Hospital A novel method for monitoring endometriosis and associated disorders
JPWO2020179895A1 (es) 2019-03-07 2020-09-10
ES2787725A1 (es) * 2019-04-15 2020-10-16 Univ Granada Metodo de obtencion de datos utiles para diagnosticar telangiectasia hemorragica hereditaria
CN110144394A (zh) * 2019-04-18 2019-08-20 辽宁省肿瘤医院 一种子宫内膜异位症诊断、预后标志物及其应用
JP7315780B2 (ja) * 2019-07-22 2023-07-26 エフ． ホフマン－ラ ロシュ アーゲー 子宮内膜症の非侵襲的診断のための血液バイオマーカーとしてのサブスタンスｐ
KR20220024782A (ko) * 2019-07-22 2022-03-03 에프. 호프만-라 로슈 아게 자궁내막증의 비침습적 진단을 위한 혈액 바이오마커로서의 s100a8
KR20220016210A (ko) * 2019-07-22 2022-02-08 에프. 호프만-라 로슈 아게 자궁내막증의 비-침습적 진단용 혈액 생물표지자로써 s100a9
US11965879B2 (en) 2019-08-23 2024-04-23 Mcmaster University Method for diagnosing and assessing endometriosis
KR102242639B1 (ko) * 2020-01-28 2021-04-21 고려대학교 산학협력단 간 섬유화 진단용 바이오마커 miRNA4668-5p
KR102316507B1 (ko) * 2020-02-28 2021-10-22 차의과학대학교 산학협력단 난소 예비력 바이오마커 및 이의 용도
CN111909997B (zh) * 2020-09-09 2021-09-28 上海交通大学 miRNA标志物在制备奥氮平治疗精神分裂症疗效评估方面的产品中的应用及试剂盒
JP2022063860A (ja) * 2020-10-12 2022-04-22 学校法人近畿大学 ホウ素化合物およびその製造方法
KR20240084586A (ko) * 2022-12-06 2024-06-14 연세대학교 산학협력단 자궁내막증 진단용 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090317820A1 (en) 2008-05-19 2009-12-24 The Regents Of The University Of California Micro-rna profile in human saliva and its use for detection of oral cancer
GB2463401B (en) 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
EP2416789B1 (en) 2009-04-07 2017-06-21 Velin-Pharma A/S Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
KR20130056855A (ko) * 2010-03-01 2013-05-30 카리스 라이프 사이언스 룩셈부르크 홀딩스 치료진단용 생물학적 지표들
JP2014513521A (ja) * 2011-01-26 2014-06-05 セファイド 肺癌を検出する方法
WO2012112883A1 (en) 2011-02-18 2012-08-23 Yale University The kras-variant and endometriosis
FR2984358A1 (fr) * 2011-12-16 2013-06-21 Genethon Methodes pour le diagnostic de dystrophies musculaires
WO2013148151A1 (en) 2012-03-29 2013-10-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Plasma microribonucleic acids as biomarkers for endometriosis and endometriosis-associated ovarian cancer
US10927412B2 (en) 2013-10-01 2021-02-23 The Regents Of The University Of California Endometriosis classifier
AU2014348273A1 (en) * 2013-11-18 2016-06-09 Diamir, Llc Methods of using mIRNAs from bodily fluids for detection and monitoring of Parkinson's disease (PD)
GB201403489D0 (en) * 2014-02-27 2014-04-16 Univ London Queen Mary Biomarkers for endometriosis
US9650676B2 (en) 2014-03-19 2017-05-16 University Of South Carolina Leukocyte MicroRNAS for use in diagnosis and treatment of endometriosis
WO2015148919A2 (en) * 2014-03-27 2015-10-01 Yale University Circulating micrornas as biomarkers for endometriosis
EP2924126B1 (en) * 2014-03-28 2018-04-18 Tervisetehnoloogiate Arenduskeskus AS Method for using microRNA (miRNA) for detection of endometriosis
GB201603967D0 (en) * 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
SG11201901834WA (en) 2016-08-30 2019-03-28 Univ Yale Micrornas as biomarkers for endometriosis
EP3676395A4 (en) 2017-08-30 2021-09-01 Dot Laboratories, Inc. METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF ENDOMETRIOSIS
US11315660B2 (en) 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
EP3873487A4 (en) 2018-10-31 2022-08-03 Yale University QUANTITATIVE ALGORITHM FOR ENDOMETRIOSIS
EP3963094A4 (en) 2019-04-29 2024-02-28 Yale University CLASSIFIERS FOR DETECTING ENDOMETRIOSIS

Also Published As

Publication number Publication date
US20190276893A1 (en) 2019-09-12
CN109890394A (zh) 2019-06-14
SG11201901834WA (en) 2019-03-28
CA3035429A1 (en) 2018-03-08
US20220049312A1 (en) 2022-02-17
SG10202102509TA (en) 2021-04-29
US20210180134A1 (en) 2021-06-17
BR112019004075A2 (pt) 2019-05-28
KR20190057305A (ko) 2019-05-28
AU2017319325A1 (en) 2019-03-21
JP2019528081A (ja) 2019-10-10
WO2018044979A1 (en) 2018-03-08
US12077803B2 (en) 2024-09-03
US11220713B2 (en) 2022-01-11
EP3506912A4 (en) 2020-08-19
JP2022188086A (ja) 2022-12-20
US10982282B2 (en) 2021-04-20
EP3506912B1 (en) 2024-04-03
EP3506912A1 (en) 2019-07-10

Similar Documents

Publication Publication Date Title
MX2019002425A (es) Micro ácidos ribonucleicos como biomarcadores para la endometriosis.
Zhang et al. A novel approach to interval-valued intuitionistic fuzzy soft set based decision making
CY1123823T1 (el) Βελτιωμενες συνθεσεις τ κυτταρων
WO2015148919A3 (en) Circulating micrornas as biomarkers for endometriosis
PH12018500647A1 (en) Affinity-oligonucleotide conjugates and uses thereof
PH12016501763B1 (en) Multispecific antibodies
SG10201807147TA (en) Verification methods and verification devices
SG10201810150UA (en) Compositions and methods for enhanced gene expression in cone cells
BR112017003414A2 (pt) composições compreendendo caseína e métodos para produzir as mesmas
PH12017500555A1 (en) Modified phosphpors and compositions thereof
MX2016009943A (es) Composiciones de nanotribologia y metodos relacionados que incluyen nanolaminas moleculares.
SG10201703658SA (en) Novel compositions, uses and methods for making them
PH12016501588B1 (en) Geocell with improved compaction and deformation resistance
MX2017007460A (es) Composicion polimerica que comprende aditivos basicos, procedimiento y articulos que comprenden dicha composicion polimerica.
FI3511422T3 (fi) Menetelmiä ja koostumuksia endometriooosin diagnosointia, ennustamista ja hoitoa varten
MX2016015893A (es) Produccion de fragmentos de fragmento cristalizable (fc).
MX2016006165A (es) Composiciones y metodos para valorar la funcion intestinal.
SG11201704288RA (en) Dynamic vulcanization of a blend composition, methods of manufacture thereof and articles comprising the same
Hong et al. Supereulerian digraphs
MX2016014227A (es) Estabilizante para procesos de produccion de poliol polimerico.
IN2014CH00151A (es)
PL3056528T3 (pl) Kompozycja kopolimeru segmentowego o udoskonalonych właściwościach
SA519410447B1 (ar) عوامل تنوي، طرق لإنتاجها، وتركيبات بوليمرية ذات صلة
Parker et al. An improved 3-local characterization of McL and its automorphism group
WO2016201217A3 (en) GFR α 1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS